RARE — Ultragenyx Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Ultragenyx Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	740	748	577	610	680
Net Total Accounts Receivable
Net Total Receivables	44.4	46.8	74.5	124	159
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	857	884	732	817	951
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	176	286	314	291	244
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,522	1,545	1,491	1,503	1,532
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	181	261	280	344	384
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	600	1,193	1,216	1,248	1,612
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	923	352	275	255	-80
Total Liabilities & Shareholders' Equity	1,522	1,545	1,491	1,503	1,532
Total Common Shares Outstanding